Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (review)

International Journal of Oncology

Volumn 31, Issue 3, 2007, Pages 473-484

  Agostinelli, Enzo ^a   Seiler, Nikolaus ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCAD   (France)

Author keywords

Colon adenocarcinoma; Lysosomes; Lysosomotropic compounds; MDL 72527; Multidrug resistance; Polyamines

Indexed keywords

ADENOSINE TRIPHOSPHATASE; HYDROGEN PEROXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE; SPERMINE;

ANIMAL; APOPTOSIS; CHEMICAL MODEL; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; ENZYMOLOGY; HUMAN; LYSOSOME; METABOLISM; NEOPLASM; REVIEW;

ADENOSINE TRIPHOSPHATASES; ANIMALS; APOPTOSIS; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, NEOPLASM; HUMANS; HYDROGEN PEROXIDE; LYSOSOMES; MODELS, CHEMICAL; NEOPLASMS; OXYGEN; REACTIVE OXYGEN SPECIES; SPERMINE;

EID: 38449100178     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.3.473     Document Type: Review

References (114)

1. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
2. Fulda S and Debatin KM: Exploiting death receptor signalling pathways for tumor therapy. Biochim Biophys Acta 1795: 27-41, 2004. (Pubitemid 39592904)
3. Jäättelä M: Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 23: 2746-2756, 2004.
4. Broker LE, Kruyt FA and Giaccone G: Cell death independent of caspases: a review. Clin Cancer Res 11: 3155-3162, 2005.
5. Kroemer G and Martin SJ: Caspase-independent cell death. Nat Med 11: 723-730, 2005.
6. Castino R, Demoz M and Isidoro C: Destination 'lysosome': a target organelle for tumor cell killing. J Mol Recognit 16: 337-348, 2003.
7. Guicciardi ME, Leist M and Gores GJ: Lysosomes in cell death. Oncogene 23: 2881-2890, 2004.
8. Cuervo AM: Autophagy in sickness and in health. Trends Cell Biol 14: 70-77, 2004.
9. Eskelinen EL: Doctor Jekyll and Mister Hyde: Autophagy can promote both cell survival and cell death. Cell Death Differ 12: 1468-1472, 2005.
10. Kroemer G and Jäättelä M: Lysosomes and autophagy in cell death control. Nat Rev Cancer 5: 886-897, 2005. (Pubitemid 41746033)
11. Fehrenbacher N and Jäättelä M: Lysosomes as targets in cancer therapy. Cancer Res 65: 2993-2995, 2005.
12. Stoka V, Turk B and Turk V: Lysosomal cysteine proteinases: structural features and their role in apoptosis. IUBMB Life 57: 347-353, 2005.
13. Kane SE and Gottesman MM: The role of cathepsin L in malignant transformation. Semin Cancer Biol 1: 127-136, 1990.
14. Koblinski JE, Ahram M and Sloane BF: Unravelling the role of proteases in cancer. Clin Chim Acta 291: 113-135, 2000.
15. Jedeszko C and Sloan BF: Cathepsins in human cancer. Biol Chem 385: 1017-1027, 2004.
16. Bursch W: The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 8: 569-581, 2001.
17. Brunk UT, Dalen H, Roberg K and Hellquist HB: Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic Biol Med 23: 616-626, 1997.
18. Seiler N and Raul F: Polyamines and apoptosis. J Cell Mol Med 9: 623-642, 2005.
19. Dai H, Kramer DL, Yanag C, Murti KG, Porter CW and Cleveland JL: The polyamine oxidase inhibitor MDL 72527 selectively induces apoptosis of transformed haematopoietic cells through lysosomotropic effects. Cancer Res 59: 4844-4954, 1999. (Pubitemid 29472900)
20. de Duve C and Wattiaux R: Functions of lysosomes. Annu Rev Physiol 28: 435-492, 1966.
21. de Duve C: The lysosome turns fifty. Nat Cell Biol 7: 847-849, 2005.
22. Codogno P and Meijer AJ: Autophagy and signalling: their role in cell survival and cell death. Cell Death Differ 12: 1509-1518, 2005.
23. Davies P and Allison AC: The secretion of lysosomal enzymes. Front Biol 45: 61-98, 1976.
24. Schwartz AL and Ciechanover A: The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50: 57-74, 1999.
25. Cuervo AM: Autophagy: Many paths to the same end. Mol Cell Biochem 263: 55-72, 2004.
26. Kos J and Lah TT: Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep 5: 1349-1361, 1998.
27. Turk B, Turk D and Turk V: Lysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta 1477: 89-111, 2000.
28. Majeski AE and Dice JF: Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 36: 2435-2444, 2004.
29. Boya P, Gonzales-Polo RA, Casares N, Perfettini J, Dessen P, Larochette N, Metivier D, Maley D, Souquere S, Yoshimori T, Pierron G, Codogno P and Kroemer G: Inhibition of macro autophagy triggers apoptosis. Mol Cell Biol 25: 1025-1040, 2005.
30. Ogier-Denis and Codogno: Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta 1603: 113-128, 2003.
31. Gozuacik D and Kimchi A: Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906, 2004. (Pubitemid 38638851)
32. Yu Z, Persson HL, Eaton JW and Brunk UT: Intralysosomal iron, a major determinant of oxidant-induced cell death. Free Radic Biol Med 34: 1243-1252, 2003. (Pubitemid 36513967)
33. Starke PE, Gilberton JD and Farber JL: Lysosomal origin of the iron required for cell killing by hydrogen peroxide. Biochem Biophys Res Commun 133(2): 371-379, 1985.
34. Brunk UT and Svensson I: Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Rep 4: 3-11, 1999.
35. 2-mediated damage to lysosomal membranes of J-774 cells. Free Radic Res Commun 18: 71-85, 1993.
36. Zhao M, Antunes F, Eaton JW and Brunk UT: Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur J Biochem 270: 3778-3786, 2003.
37. Yu Z, Li W, Hillman J and Brunk UT: Human neuroblastoma (SH-SY5Y) is highly sensitive to the lysosomotropic aldehyde 3-aminopropanal. Brain Res 1016: 163-169, 2004.
38. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M and Jäättelä M: Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 153: 999-1010, 2001.
39. Deiss LP, Galinka H, Berissi H, Cohen O and Kimchi A: Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/Apo-1 and TNF-α. EMBO J 15: 3861-3870, 1996.
40. Kågedal K, Johansson U and Ollinger K: The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 15: 1592-1594, 2001.
41. Bidere N, Lorenzo HK, Carmona S, Ladorge M, Harper F, Dumont C and Senik A: Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 278: 31401-31411, 2003. (Pubitemid 36994661)
42. Erdal H, Berndtsson M, Castro J, Brunk U, Shoshan MC and Linder S: Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 102: 192-197, 2005.
43. Zang Y, Beard RL, Chandraratna RA and Kanag JX: Evidence for a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukaemia HL-60 cells. Cell Death Differ 8: 477-485, 2001.
44. Szatrowsky TP and Nathan CE: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798, 1991.
45. Boya P, Gonzales-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, Perfettini JL and Kroemer G: Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22: 3927-3936, 2003.
46. Boya P, Andreau K, Poncet T, Zamzami N, Perfettini J, Metivier D, Ojcius DM, Jäättelä M and Kroemer G: Lysosomal membrane permeabilisation induces cell death in a mitochondrion-dependent fashion. J Exp Med 197: 1323-1334, 2003.
47. Kågedal K, Johansson AC, Johansson U, Heimlich G, Roberg K, Wang NS, Jürgensmeier JM and Ollinger K: Lysosomal membrane permeabilization during apoptosis-involvement of Bax? Int J Exp Pathol 86: 308-321, 2005.
48. Fischer J, Lullmann H and Lullman-Rauch R: Drug-induced lysosomal storage of sulphated glycosaminoglycans. Gen Pharmacol 27: 1317-1324, 1996. (Pubitemid 26419688)
49. Shau H and Dawson JR: Regulation of human natural killing by lysosomotropic and thiol-reactive agents. Immunology 55: 647-654, 1985. (Pubitemid 15237672)
50. Ziegler HK and Unanue ER: Decrease in macrophage antigen metabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 79: 175-178, 1982.
51. Steinberg TH: Cellular transport of drugs. Clin Infect Dis 19: 916-921, 1994.
52. Miller DK, Griffiths E, Lenard J and Firestone RA: Cell killing by lysosomotropic detergents. J Cell Biol 97: 1841-1851, 1983.
53. Drose S and Altendorf K: Bafilomycins and concanamycins as inhibitors of V-ATPases. J Exp Biol 200: 1-8, 1997.
54. +-translocating vacuolartype ATPase in the anterior silk gland cell of Bombyx mori during metamorphosis. J Exp Biol 201: 479-486, 1998.
55. +- ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1. J Biochem 134: 359-364, 2003.
56. Tanigaki K, Sasaki S and Ohkuma S: In bafilomycin A1-resistant cells, bafilomycin A1 raised lysosomal pH and both prodigiosins and concanamycin A inhibited growth through apoptosis. FEBS Lett 537: 79-84, 2003.
57. Yoshikawa T, Kokura S, Tanaka K, Naito T and Kondo M: A novel cancer therapy based on oxygen radicals. Cancer Res 55: 1617-1620, 1995.
58. Agostinelli E, Arancia G, Dalla Vedova L, Belli F, Marra M, Salvi M and Toninello A: The biological functions of polyamine oxidation products by amine oxidases. Perspectives of clinical applications. Amino Acids 27: 347-358, 2004.
59. Park J, Choi K, Jeong E, Kwon D, Benveniste EN and Choi C: Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells. Glia 47: 9-20, 2004.
60. Yuan XM, Li W, Dalen H, Lotem J, Kama R, Sachs L and Brunk UT: Lysosomal destabilization in p53-induced apoptosis. Proc Natl Acad Sci USA 99: 6286-6294, 2002.
61. Ivanova S, Botchkina GL, Al-Abed Y, Meistrell M III, Batliwalla F, Dubinsky JM, Iadecola C, Wang H, Gregerssen PK, Eaton JW and Tracey KJ: Cerebral ischemia enhances polyamine oxidation: Identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death. J Exp Med 188: 327-340, 1998.
62. Wang Y, Devereux W, Woster PM, Stewart TM, Hacker A and Casero RA Jr: Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res 64: 5370-5373, 2001.
63. Zeilhofer HU, Mollenhauer J and Brune K: Selective growth inhibition of ductal pancreatic adenocarcinoma cells by the lysosomotropic agent chloroquine. Cancer Lett 44: 61-66, 1989. (Pubitemid 19050963)
64. Seiler N, Chaabi M, Roussi S, Gosse F, Lobstein A and Raul F: Synergism between apple procyanidins and lysosomotropic drugs: potential in chemoprevention. Anticancer Res 26: 3381-3385, 2006.
65. Zamora JM and Beck WT: Chloroquine enhancement of anticancer drug cytotoxicity in drug-resistant human leukaemia cells. Biochem Pharmacol 35(23): 4303-4310, 1986.
66. Shiraishi N, Akiyama S, Kobayashi M and Kuwano M: Lysosomotropic agents reverse multidrug resistance in human cancer cells. Cancer Lett 30: 251-259, 1986. (Pubitemid 16141895)
67. Seiler N, Duranton B and Raul F: The polyamine oxidase inactivator MDL 72527. Prog Drug Res 59: 1-40, 2002.
68. Brunton VG, Grant MH and Wallace HM: Mechanism of spermine toxicity in baby hamster kidney (BHK) cells. Biochem J 280: 193-198, 1991.
69. Seiler N, Duranton B, Gossé F and Raul F: Spermine cytotoxicity to human colon carcinoma-derived cells (CaCo-2). Cell Biol Toxicol 16: 117-130, 2000.
70. 1-(n-octanesulfonyl) spermine and human colon cancer cells. Int J Biochem Cell Biol 32: 703-716, 2000.
71. 1-(n-octanesulfonyl)spermine toxicity. Int J Biochem Cell Biol 32: 1055-1068, 2000.
72. Seiler N, Renault J, Gossé F, Roussi S and Raul F: Cytotoxicity of the polyamine oxidase inactivator MDL 72527 to cancer cells: comparison with a saturated structural analogue. Int J Oncol 27: 1669-1676, 2005.
73. Duranton B, Holl V, Schneider Y, Carnesecchi S, Gosse F, Raul F and Seiler N: Cytotoxic effects of the polyamine oxidase inactivator MDL 72527 on two human colon carcinoma cell lines SW 440 and SW 620. Cell Biol Toxicol 18: 381-396, 2002.
74. Agostinelli E, Dalla Vedova L, Belli F, Condello M, Arancia G and Seiler N: Sensitization of human colon adenocarcinoma cells (LoVo) to reactive oxygen species by a lysosomotropic compound. Int J Oncol 29: 947-955, 2006.
75. Agostinelli E, Belli F, Molinari A, Condello M, Palmigiani P, Marra M, Seiler N and Arancia G: Toxicity of enzymatic oxidation products of spermine to human melanoma cells (M14): sensitisation by heat and MDL 72527. Biochim Biophys Acta 1763: 1040-1050, 2006.
76. Loo TW and Clarke DM: Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J Membr Biol 206: 173-185, 2005.
77. Gottesman MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993. (Pubitemid 23237876)
78. Breier A, Barancik M, Sulova Z and Uhrik B: P-glycoprotein: implications of metabolism of neoplastic cells and cancer therapy. Curr Cancer Drug Targets 5: 457-468, 2005.
79. Szabo D, Keyzer H, Kaiser HE and Molnar J: Reversal of multidrug resistance of tumor cells. Anticancer Res 20: 4261-4274, 2000.
80. Wadkins RM and Roepe PD: Biophysical aspects of Pglycoprotein-mediated multidrug resistance. Int Rev Cytol 171: 121-165, 1997. (Pubitemid 127742465)
81. Zamora JM, Pearce HL and Beck WT: Physical chemical properties shared by compounds that modulate multidrug-resistance in human leukaemic cells. Mol Pharmacol 33: 454-462, 1988.
82. Skovsgaard T, Dano K and Nissen NI: Chemosensitizers counteracting acquired resistance to anthracyclines and Vinca alkaloids in vivo. A new treatment principle. Cancer Treat Rev 11 (Suppl A9): 63-72, 1984.
83. 10-substituted phenoxazines for reversing multidrug resistance in cancer cells. Oncol Res 10: 29-41, 1998.
84. Choi SU, Park SH, Kim KH, Choi EJ, Kim S, Park WK, Zhang YH, Kim HS, Jung NP and Lee CO: The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein. Anticancer Drugs 9: 255-261, 1998.
85. Rothenborg-Jensen L, Hansen HF, Wessel I, Nitiss JL, Schmidt G, Jensen PB, Sehested M and Jensen LH: Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines. Anticancer Drug Des 16: 305-315, 2001.
86. Vezmar M and Georges E: Direct binding of chloroquine to the multidrug resistance protein (MRP): possible role for MRP in chloroquine drug transport and resistance in tumor cells. Biochem Pharmacol 56: 733-742, 1998.
87. Akiyama S, Gottesman MM, Hanover JA, Fitzgerald DJP, Willingham MC and Pastan I: Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin. J Cell Physiol 120: 271-279, 1984.
88. Akiyama S, Tomita K and Kuwano M: The effect of calcium antagonists on the proteolytic degradation of low density lipoprotein in HeLa cells. Exp Cell Res 158: 192-204, 1985. (Pubitemid 15045832)
89. Gosland MP, Gillespie MN, Tsuboi CP, Tofig S, Olson JW, Crooks PA and Aziz SM: Reversal of doxorubicin, etoposide, vinblastine and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine. Cancer Chemother Pharmacol 37: 593-600, 1996.
90. Drori S, Eytan GD and Assaraf YG: Potentiation of anticancer drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur J Biochem 228: 1020-1029, 1995.
91. Dorr RT and Liddil ID: Modulation of Mitomycin C-induced multidrug resistance in vitro. Cancer Chemother Pharmacol 27: 290-294, 1991.
92. Klohs WD and Steinkampf RW: The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity of multiple drug-resistant cells. Mol Pharmacol 34: 180-185, 1988.
93. Dudeja PK, Anderson KM, Harris JS, Buckingham L and Coon JS: Reversal of multidrug resistant phenotype: relationship to membrane lipid fluidity. Arch Biochem Biophys 319: 309-315, 1995.
94. Averill-Bates DA, Cherif A, Agostinelli E, Tanel A and Fortier G: Antitumoral effect of native and immobilized bovine serum amine oxidase in a mouse melanoma model. Biochem Pharmacol 69: 1693-1700, 2005.
95. Lee YJ and Shacter E: Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo. Free Radic Biol Med 29: 684-692, 2000.
96. Teramoto S, Tomita T, Matsui H, Ohga E, Matsuse T and Ouchi Y: Hydrogen peroxide-induced apoptosis and necrosis in human lung fibroblasts: protective roles of glutathione. Jpn J Pharmacol 79: 33-40, 1999.
97. Kern JC and Kehrer JP: Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chem Biol Interact 139: 79-95, 2002.
98. Calcabrini A, Arancia G, Marra M, Crateri P, Befani O, Martone A and Agostinelli E: Enzymatic oxidation product of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild type counterparts. Int J Cancer 99: 43-52, 2002.
99. Agostinelli E, Arancia G, Calcabrini A, Matarrese P, Mondovì B and Pietrangeli P: Hyperthermia-induced biochemical and ultrastructural modifications in cultured cells. Exp Oncol 17: 269-276, 1995.
100. Agostinelli E, Belli F, Dalla Vedova L, Marra M, Crateri P and Arancia G: Hyperthermia enhances cytotoxicity of amine oxidase and spermine on drug-resistant colon adenocarcinoma cells (LoVo). Int J Oncol 28: 1543-1553, 2006.
101. Demers N, Agostinelli E, Averill-Bates DA and Fortier G: Immobilization of native and poly(ethylene glycol)-treated ('PEGylated') bovine serum amine oxidase into a biocompatible hydrogel. Biotechnol Appl Biochem 33: 201-207, 2001.
102. Heby O and Persson L: Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci 15: 153-158, 1990. (Pubitemid 20186844)
103. Fehrenbacher N, Gyrd-Hansen M, Poulsen B, Felbor U, Kallunki T, Boes M, Weber E, Leist M and Jäättelä M: Sensitization to the lysosomal cell death pathway upon immortalization and transformation. Cancer Res 64: 5301-5310, 2004.
104. Urano M, Kuroda M and Nishimura Y: For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 15: 79-107, 1999.
105. Ginsburg H: Should chloroquine be laid to rest? Acta Trop 96: 16-23, 2005.
106. Savarino A, Di Trani L, Donatelli I, Cauda R and Cassone A: New insights into the antiviral effects of chloroquine. Lancet Infect Dis 6: 67-69, 2006.
107. Briceno E, Reyes S and Sotelo J: Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine. Neurosurg Focus 14: e3, 2003.
108. Porter CW, Stanek J, Black J, Vaughan M, Ganis B and Pleshkewych A: Morphological evidence for an apparent lysosomotropic activity by unsaturated putrescine analogues. Cancer Res 50: 1929-1935, 1990.
109. Rosenfeld CS: Antileukemic activity of phenylalanine methyl ester (PME): a lysosomotropic peptide methyl ester. Stem Cells 12: 198-204, 1994.
110. Jadot M, Bielande V, Beauloye V, Wattiaux-de Conick S and Wattiaux R: Cytotoxicity and effect of glycyl-D-phenylalanine-2-naphthylamide on lysosomes. Biochim Biophys Acta 1027: 205-209, 1990.
111. Uchimoto T, Nohara H, Kamehara R, Iwamura M, Watanabe N and Kobayashi T: Mechanism of apoptosis induced by lysosomotropic agent L-leucyl-L-leucine methyl ester. Apoptosis 4: 357-362, 1999.
112. Mizuta H, Watanabe S, Sakurai Y, Nishiyama K, Furuta T, Kobayashi Y and Iwamura M: Design, synthesis, photochemical properties and cytotoxic activities of water-soluble caged Lleucyl-L-leucine methyl esters that control apoptosis of immune cells. Bioorg Med Chem 10: 675-683, 2002. (Pubitemid 34112460)
113. Lullmann-Rauch R, Pods R and Von Witzendorff B: Tilorone-induced lysosomal storage of sulphated glycosaminoglycans can be separated from tilorone-induced enhancement of lysosomal enzyme secretion. Biochem Pharmacol 49: 1223-1233, 1995.
114. Li W, Yuan XM, Ivanova S, Tracey KJ, Eaton JW and Brunk UT: 3-Aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin. Biochem J 371: 429-436, 2003.